본문 바로가기
KERD
논문KCI 등재

항톡소포자충 효과를 가진 천연물 유래 추출물에 관한 연구

Anti-Toxoplasmosis effects of herbal extracts against Toxoplasma Gondii

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류수의학

초록

Toxoplasmosis is a parasitic disease caused by Toxoplasma gondii, with very few therapeutic treatment options. The choices for treatment are pyrimethamine and sulfadiazine, however their utility is limited because of drug toxicity and serious side effects. In this study, ethanol extracts of 13 traditional medi-cines used to treat Toxoplasma gondii were tested in vitro for their anti-Toxoplasma gondii cytotoxicity. The median effective concentration (EC50) values for the herbal extracts ranged from 173 mg/mL to 1995.35 mg/mL. In HeLa cell, the selectivity of Alpinia oxyphylla (2.75), Mucunae Caulis (2.96), Dictamnus dasycarpus (7.52) which was higher than sulfadiazine (2.08). This indicates that Alpinia oxy-phylla, Mucunae Caulis, Dictamnus dasycarpus extracts may be sources of new anti-Toxoplasma gondii compounds.

Abstract

Toxoplasmosis is a parasitic disease caused by Toxoplasma gondii, with very few therapeutic treatment options. The choices for treatment are pyrimethamine and sulfadiazine, however their utility is limited because of drug toxicity and serious side effects. In this study, ethanol extracts of 13 traditional medi-cines used to treat Toxoplasma gondii were tested in vitro for their anti-Toxoplasma gondii cytotoxicity. The median effective concentration (EC50) values for the herbal extracts ranged from 173 mg/mL to 1995.35 mg/mL. In HeLa cell, the selectivity of Alpinia oxyphylla (2.75), Mucunae Caulis (2.96), Dictamnus dasycarpus (7.52) which was higher than sulfadiazine (2.08). This indicates that Alpinia oxy-phylla, Mucunae Caulis, Dictamnus dasycarpus extracts may be sources of new anti-Toxoplasma gondii compounds.

참고문헌 (9)

  1. Djurković-Djaković O, "Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic(Me49)strain of Toxoplasma gondii", J Antimicrob Chemother, 50(6), pp.981~987 (2002)
  2. Ferreira R, "Toxoplasma gondii: In vitro and in vivo activities of the hydroxy naphthoquinone 2-hydroxy-3-(1`-propen- 3-phenyl)-1, 4-naphthoquinone alone or combined with sulphadiazine", Exp Parasitol, 113, pp.125~129 (2006)
  3. Hoffman SL, "Plasmodium, human and anopheles genomics and malaria", Nature, 415, pp.702~709 (2000)
  4. 김혜경, "한약제 진피의 항 톡소포자충 효과 확인", 동의생리병리학회지, 22(1), pp.96~99 (2008), 대한동의병리학회
  5. Lee DC, "A case of comgenital Toxoplasmosis in the Neonate", J Korean Ophthalmol Soc, 40(5), pp.247~252 (1999)
  6. 박지영, "선천형 톡소플라즈마증 환아의 증례보고", 대한소아치과학회지, 34(3), pp.526~531 (2007), 대한소아치과학회
  7. Petersen E, "Toxoplasmosis", Seminars in Fetal & Neonatal Medicine, 12, pp.214~223 (2007)
  8. 송현욱, "Influence of calcium ion on host cell invasion and intracellular replication by Toxoplasma gondii", The Korean Journal of Parasitology, 42(4), pp.185~193 (2004), 대한기생충학회
  9. Tenter AM, "Toxoplasma gondii : from animals to humans", International Journal for Parasitology, 30, pp.1217~1258 (2000)

관련 논문AI추천

이 간행물의 다른 논문 (7건)